🔥 biotech 핫 테마 분석

S-Class [DNA] Ginkgo Bioworks surges 21%; up 120% over last month

S-Class [GMAB] Genmab, AbbVie data boosts Epkinly as first-line B-cell lymphoma treatment

[RGNX] Regenxbio a new Outperform at Mizuho on potential of two pipeline drugs

S-Class [ACB] Curaleaf enhances offer to acquire Aurora Cannabis

S-Class [ALVO] FDA approves additional U.S. manufacturing capacity for Simlandi, Alvotech’s biosimilar to Humira

[LLY] Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s

Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.

S-Class [SMMT] AstraZeneca, Daiichi Sankyo partner with Summit on cancer trial